Funding for Medical Research
and Clinical Trials
and Clinical Trials
Funding Details for Cancer
Use the contact information shown for the organization to apply for the funding.
Please notify CenTrial of any offer is incorrect or has expired.
Please notify CenTrial of any offer is incorrect or has expired.
Children’s Tumor
Children’s Tumor Foundation
Type of Organization: Foundation
Email Address: ctfgrants@altum.com
Funds Available for Clinical Trials: ✗ Research: ✔
MD, PhD or equivalent
Must have full access to or identified collaborators with required resources including in vivo and in vitro models
Applicants from industry can apply
No citizenship requirement
Other info: The goal of the Drug Discovery Initiative (DDI) program is to stimulate NF drug discovery by funding researchers proposing to investigate novel or repurposing therapies for NF or to validate new NF targets. Proposals are expected to be short and concentrated on obtaining key preliminary data needed to quickly advance to the next step of drug discovery.
Specifically, applications must fall into one the following two categories:
Support early-stage testing of therapeutic compounds for the treatment of NF. Shelved compounds (compounds having successfully undergone clinical testing but not being actively developed further despite this) will be prioritized. For compounds against a specific target (where multiple compounds exist), a strong rationale, also based on safety data, must be provided upon submission.
Support the validation of a novel NF target. Targets may have been described as potentially relevant in NF or may be de novo. To that end, we encourage the mining of existing publicly available datasets. Target validation experiments should not be limited to the testing of compounds of limited or unknown specificity and should include target engagement experiments using direct biochemical methods or genetic interactions.
Children’s Tumor Foundation
Type of Organization: Foundation
Email Address: ctfgrants@altum.com
Funds Available for Clinical Trials: ✗ Research: ✔
Funding Details
Requirements: EligibilityMD, PhD or equivalent
Must have full access to or identified collaborators with required resources including in vivo and in vitro models
Applicants from industry can apply
No citizenship requirement
Other info: The goal of the Drug Discovery Initiative (DDI) program is to stimulate NF drug discovery by funding researchers proposing to investigate novel or repurposing therapies for NF or to validate new NF targets. Proposals are expected to be short and concentrated on obtaining key preliminary data needed to quickly advance to the next step of drug discovery.
Specifically, applications must fall into one the following two categories:
Support early-stage testing of therapeutic compounds for the treatment of NF. Shelved compounds (compounds having successfully undergone clinical testing but not being actively developed further despite this) will be prioritized. For compounds against a specific target (where multiple compounds exist), a strong rationale, also based on safety data, must be provided upon submission.
Support the validation of a novel NF target. Targets may have been described as potentially relevant in NF or may be de novo. To that end, we encourage the mining of existing publicly available datasets. Target validation experiments should not be limited to the testing of compounds of limited or unknown specificity and should include target engagement experiments using direct biochemical methods or genetic interactions.